While T2D was traditionally considered a metabolic disease resulting from insulin resistance and insufficient insulin production, recent genetic, epidemiological, and cytokine profiling studies have supported the idea that chronic low-grade activation of the immune system may also play a role in the development of T2D (2–7). The gene discussed is INS; the disease is type 2 diabetes mellitus.